Diagnosis of idiopathic pulmonary fibrosis An Official ATS/ERS/JRS/ALAT Clinical practice guideline

Luca Richeldi, Ganesh Raghu, Martine Remy-Jardin, Jeffrey L. Myers, Christopher J. Ryerson, David J. Lederer, Juergen Behr, Vincent Cottin, Sonye K. Danoff, Ferran Morell, Kevin R. Flaherty, Athol Wells, Fernando J. Martinez, Arata Azuma, Thomas J. Bice, Demosthenes Bouros, Kevin K. Brown, Harold R. Collard, Abhijit Duggal, Liam GalvinYoshikazu Inoue, R. Gisli Jenkins, Takeshi Johkoh, Ella A. Kazerooni, Masanori Kitaichi, Shandra L. Knight, George Mansour, Andrew G. Nicholson, Sudhakar N.J. Pipavath, Ivette Buendía-Roldán, Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson

Risultato della ricerca: Contributo in rivistaArticolo in rivista

811 Citazioni (Scopus)

Abstract

Background: This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Methods: The evidence syntheses were discussed and recommendations formulated by a multidisciplinary committee of IPF experts. The evidence was appraised and recommendations were formulated, written, and graded using the Grading of Recommendations, Assessment, Development, and Evaluation approach. Results: The guideline panel updated the diagnostic criteria for IPF Previously defined patterns of usual interstitial pneumonia (UIP) were refined to patterns of UIP, probable UIP, indeterminate, and alternate diagnosis. For patients with newly detected interstitial lung disease (ILD) who have a high-resolution computed tomography scan pattern of probable UIP, indeterminate, or an alternative diagnosis, conditional recommendations were made for performing BAL and surgical lung biopsy; because of lack of evidence, no recommendation was made for or against performing transbronchial lung biopsy or lung cryobiopsy. In contrast, for patients with newly detected ILD who have a high-resolution computed tomography scan pattern of UIP, strong recommendations were made against performing surgical lung biopsy, transbronchial lung biopsy, and lung cryobiopsy, and a conditional recommendation was made against performing BAL. Additional recommendations included a conditional recommendation for multidisciplinary discussion and a strong recommendation against measurement of serum biomarkers for the sole purpose of distinguishing IPF from other ILDs. Conclusions: The guideline panel provided recommendations related to the diagnosis of IPF.
Lingua originaleEnglish
pagine (da-a)e44-e68
Numero di pagine25
RivistaAmerican Journal of Respiratory and Critical Care Medicine
Volume198
DOI
Stato di pubblicazionePubblicato - 2018

Keywords

  • Biopsy
  • Europe
  • Humans
  • Idiopathic Pulmonary Fibrosis
  • Idiopathic pulmonary fibrosis
  • Interstitial lung disease
  • Japan
  • Latin America
  • Lung
  • Pulmonary fibrosis
  • Societies, Medical
  • Tomography, X-Ray Computed
  • United States

Fingerprint Entra nei temi di ricerca di 'Diagnosis of idiopathic pulmonary fibrosis An Official ATS/ERS/JRS/ALAT Clinical practice guideline'. Insieme formano una fingerprint unica.

Cita questo